BR112019000742A2 - método e kit para analisar uma amostra - Google Patents

método e kit para analisar uma amostra

Info

Publication number
BR112019000742A2
BR112019000742A2 BR112019000742A BR112019000742A BR112019000742A2 BR 112019000742 A2 BR112019000742 A2 BR 112019000742A2 BR 112019000742 A BR112019000742 A BR 112019000742A BR 112019000742 A BR112019000742 A BR 112019000742A BR 112019000742 A2 BR112019000742 A2 BR 112019000742A2
Authority
BR
Brazil
Prior art keywords
light response
kit
analyzing
sample
analyte
Prior art date
Application number
BR112019000742A
Other languages
English (en)
Other versions
BR112019000742B1 (pt
Inventor
V Vu Binh
Augusto RUIZ RUIZ Federico
Kim Jinsu
Antonio Rito Palomares Marco
Olga Vásquez Villegas Patricia
C Willson Richard
Original Assignee
Inst Tecnologico Y De Estudios Superiores De Monterrey Itesm
Univ Houston System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Tecnologico Y De Estudios Superiores De Monterrey Itesm, Univ Houston System filed Critical Inst Tecnologico Y De Estudios Superiores De Monterrey Itesm
Publication of BR112019000742A2 publication Critical patent/BR112019000742A2/pt
Publication of BR112019000742B1 publication Critical patent/BR112019000742B1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/62—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N2021/755—Comparing readings with/without reagents, or before/after reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Abstract

a presente invenção refere-se a métodos, dispositivos e kit para analisar uma amostra contendo 1,5-anidroglucitol e um primeiro analito através de uma ou mais reações quimioluminescentes. alguns exemplos de realização incluem a medição de uma primeira resposta luminosa resultante de uma primeira reação quimioluminescente e a medição de uma segunda resposta luminosa resultante de uma segunda reação quimioluminescente. determinados exemplos de realização também incluem a comparação da primeira resposta luminosa em relação à segunda resposta luminosa para determinar uma relação entre 1,5-anidroglucitol e o primeiro analito.
BR112019000742-3A 2016-07-29 2017-07-27 Método e kit para analisar uma amostra BR112019000742B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662368516P 2016-07-29 2016-07-29
US62/368,516 2016-07-29
PCT/US2017/044173 WO2018022883A1 (en) 2016-07-29 2017-07-27 Systems and methods for detection of chemiluminescent reactions

Publications (2)

Publication Number Publication Date
BR112019000742A2 true BR112019000742A2 (pt) 2019-05-07
BR112019000742B1 BR112019000742B1 (pt) 2022-12-06

Family

ID=61009549

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019000742-3A BR112019000742B1 (pt) 2016-07-29 2017-07-27 Método e kit para analisar uma amostra

Country Status (5)

Country Link
US (2) US11307146B2 (pt)
CN (1) CN109312287A (pt)
BR (1) BR112019000742B1 (pt)
MX (1) MX2019001134A (pt)
WO (1) WO2018022883A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107209969B (zh) * 2014-11-03 2020-01-03 贝鲁特美国大学 使用基于先进的光谱技术检测欺诈的智能防伪光学系统(sacos)
GB2571763A (en) * 2018-03-08 2019-09-11 Sumitomo Chemical Co Enzyme-amplified lateral flow device
WO2019221841A1 (en) * 2018-05-18 2019-11-21 Nanobio Systems Inc Detection of 1, 5-anhydroglucitol (1, 5-ag) in saliva
EP3793443A4 (en) * 2018-05-18 2022-03-02 Nanobio Systems Inc COLLECTION AND TREATMENT OF A BIOLOGICAL FLUID SAMPLE
WO2020041591A1 (en) * 2018-08-24 2020-02-27 Wilson Richard C Chemical detection assays
KR20210106417A (ko) * 2018-11-07 2021-08-30 유니버시티 오브 휴스턴 시스템 비-효소적 광 분석법
CN110243793A (zh) * 2019-06-19 2019-09-17 中国人民大学 一种化学发光光纤生物传感器
CN114076755B (zh) * 2020-08-21 2024-03-12 湖南省医疗器械检验检测所 化学发光免疫分析仪用可调控参考光源
CN113340441A (zh) * 2021-07-09 2021-09-03 中国科学技术大学 发光检测系统
CN113607717A (zh) * 2021-08-03 2021-11-05 深圳市和来生物技术有限公司 化学发光的检测方法、装置与系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3784610T2 (de) * 1986-09-22 1993-09-23 Nippon Kayaku Kk Verfahren zur bestimmung von 1,5-anhydroglucitol und ausruestung dafuer.
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US6068979A (en) * 1998-04-22 2000-05-30 Lumigen, Inc. Simplified sequential chemiluminescent detection
JP5079958B2 (ja) * 1999-07-21 2012-11-21 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー 発光検知ワークステーション
US6949377B2 (en) 2001-03-05 2005-09-27 Ho Winston Z Chemiluminescence-based microfluidic biochip
CA2614299C (en) * 2005-06-13 2014-06-03 Nippon Kayaku Kabushiki Kaisha Method of assaying blood component by using whole blood and measurement kit
US8007999B2 (en) * 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
WO2008072702A1 (ja) 2006-12-14 2008-06-19 Nippon Kayaku Kabushiki Kaisha 全血中の１，５－アンヒドログルシトールの測定方法、それに用いるセンサーチップ及び測定キット
US8883439B2 (en) * 2008-07-23 2014-11-11 Nippon Kayaku Kabushiki Kaisha Blood component measurement method utilizing hemolyzed whole blood, and kit for the method
WO2012054555A2 (en) * 2010-10-20 2012-04-26 Glycomark, Inc. Improved identification of pre-diabetes using a combination of mean glucose and 1,5-anhydroglucitol markers
CN102154442B (zh) * 2010-12-30 2017-02-08 北京九强生物技术股份有限公司 1,5‑脱水山梨醇的检测方法和相关诊断试剂盒
US9005901B2 (en) * 2013-03-15 2015-04-14 Abbott Laboratories Assay with internal calibration
CN103513037A (zh) * 2013-08-09 2014-01-15 北京润诺思医疗科技有限公司 一种人胰岛素原化学发光免疫分析测定试剂盒及其制备方法

Also Published As

Publication number Publication date
CN109312287A (zh) 2019-02-05
US20180031484A1 (en) 2018-02-01
US20220221408A1 (en) 2022-07-14
US11307146B2 (en) 2022-04-19
WO2018022883A1 (en) 2018-02-01
BR112019000742B1 (pt) 2022-12-06
MX2019001134A (es) 2019-04-11

Similar Documents

Publication Publication Date Title
BR112019000742A2 (pt) método e kit para analisar uma amostra
BR112014007214A2 (pt) predição de evento de risco cardiovascular e utilização do mesmo
CO2019002608A2 (es) Biomarcadores de arn para angioedema hereditario
WO2015193325A3 (en) Ceramides and their use in diagnosing cvd
BR112021024111A2 (pt) Determinação de antidepressivos por espetrometria de massa
BR112016006312A2 (pt) método e kit para determinar a presença ou ausência de staphylococcus aureus resistente à meticilina em uma amostra biológica
BR112018067435A2 (pt) kit de espectrometria de massa
BR112018006843A2 (pt) sistema de fluxo e métodos para contagem digital
NZ751481A (en) Metabolite biomarkers for diseases associated with the contact activation system
BR112017023726A2 (pt) detecção de fatores de virulência microbiana na cavidade oral
BR112022011676A2 (pt) Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método
BR112017004207A2 (pt) dispositivo de teste e método para testar analito em amostra coletada
BR112019007121A2 (pt) cartucho, sistema de análise e método para testagem de uma amostra
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
BR112022008217A2 (pt) Métodos e dispositivos para sequenciamento
CO2019002599A2 (es) Biomarcadores proteicos para enfermedades asociadas con el sistema de activación por contacto
BR112018000560A2 (pt) método para rastrear a disseminação da infecção, e sistema para rastrear a disseminação da infecção
UA111430U (uk) Спосіб діагностики розвитку остеопорозу
UA110089U (uk) Спосіб діагностики розвитку остеопорозу
UA108365U (uk) Спосіб діагностики розвитку остеопорозу
UA111370U (uk) Спосіб діагностики розвитку остеопорозу
UA109437U (uk) Спосіб діагностики розвитку остеопорозу
UA108657U (uk) Спосіб діагностики розвитку остеопорозу
UA110746U (uk) Спосіб діагностики розвитку остеопорозу
UA111780U (uk) Спосіб діагностики розвитку остеопорозу

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/07/2017, OBSERVADAS AS CONDICOES LEGAIS